2021 annual financial data
Neuphoria Therapeutics 2021 Operating cash flow margin
Neuphoria Therapeutics 2021 operating cash flow margin with verified reported v…
Direct answer
Operating cash flow margin was -610.66%.
Operating income was -8,957,654 USD and net income was -6,534,408 USD.
Operating cash flow was -5,664,125 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 927,544 USD
- Operating income
- -8,957,654 USD
- Net income
- -6,534,408 USD
- Operating cash flow
- -5,664,125 USD